CCXI
Price:
$51.99
Market Cap:
$0
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for ...[Read more]
Industry
Biotechnology
IPO Date
2012-02-08
Stock Exchange
NASDAQ
Ticker
CCXI
According to ChemoCentryx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -45263000.00. This represents a change of -102.48% compared to the average of 1.83B of the last 4 quarters.
The mean historical Enterprise Value of ChemoCentryx, Inc. over the last ten years is 1.12B. The current -45263000.00 Enterprise Value has changed -503.28% with respect to the historical average. Over the past ten years (40 quarters), CCXI's Enterprise Value was at its highest in in the December 2020 quarter at 4.28B. The Enterprise Value was at its lowest in in the March 2016 quarter at 96.83M.
Average
1.12B
Median
361.24M
Minimum
226.98M
Maximum
4.06B
Discovering the peaks and valleys of ChemoCentryx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 226.39%
Maximum Annual Enterprise Value = 4.06B
Minimum Annual Increase = -42.21%
Minimum Annual Enterprise Value = 226.98M
| Year | Enterprise Value | Change |
|---|---|---|
| 2021 | 2.35B | -42.21% |
| 2020 | 4.06B | 81.88% |
| 2019 | 2.23B | 226.39% |
| 2018 | 683.97M | 101.18% |
| 2017 | 339.98M | 2.54% |
| 2016 | 331.57M | -3.24% |
| 2015 | 342.69M | 22.61% |
| 2014 | 279.49M | 23.14% |
| 2013 | 226.98M | -40.24% |
| 2012 | 379.79M | 5.90% |
The current Enterprise Value of ChemoCentryx, Inc. (CCXI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.88B
5-year avg
1.93B
10-year avg
1.12B
ChemoCentryx, Inc.’s Enterprise Value is less than CymaBay Therapeutics, Inc. (3.64B), less than RayzeBio, Inc. Common Stock (3.63B), less than SpringWorks Therapeutics, Inc. (3.48B), less than Mirati Therapeutics, Inc. (3.93B), less than Opthea Limited (462.97M), less than Morphic Holding, Inc. (2.81B), less than MorphoSys AG (2.93B), less than Chinook Therapeutics, Inc. (2.63B), less than Longboard Pharmaceuticals, Inc. (2.32B), less than Alpine Immune Sciences, Inc. (4.42B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.64B | $3.73B | |
| 3.63B | $3.75B | |
| 3.48B | $3.54B | |
| 3.93B | $4.12B | |
| 462.97M | $4.24B | |
| 2.81B | $2.86B | |
| 2.93B | $2.86B | |
| 2.63B | $2.71B | |
| 2.32B | $2.34B | |
| 4.42B | $4.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChemoCentryx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ChemoCentryx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ChemoCentryx, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ChemoCentryx, Inc. (CCXI)?
What is the 3-year average Enterprise Value for ChemoCentryx, Inc. (CCXI)?
What is the 5-year average Enterprise Value for ChemoCentryx, Inc. (CCXI)?
How does the current Enterprise Value for ChemoCentryx, Inc. (CCXI) compare to its historical average?